<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: drug compounds</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Building better blood vessels could advance tissue engineering</title>
   	 <description>One of the major obstacles to growing new organs—replacement hearts, lungs and kidneys—is the difficulty researchers face in building blood vessels that keep the tissues alive, but new findings from the University of Michigan could help overcome this roadblock.</description>
     <link>http://medicalxpress.com/news/2013-04-blood-vessels-advance-tissue.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 04 Apr 2013 15:46:49 EST</pubDate>
	 <guid isPermaLink="false">news284309201</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/buildingbett.jpg" width="90" height="90" />
</item>
<item>
     <title>A nanogel-based treatment for lupus</title>
   	 <description>Systemic lupus erythematosus (SLE) is disease in which the immune system mistakenly attacks healthy tissues, resulting in inflammation and tissue damage. Current treatments are focused on suppression of the immune system, but these therapies can leave patients vulnerable to infection.</description>
     <link>http://medicalxpress.com/news/2013-03-nanogel-based-treatment-lupus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 01 Mar 2013 12:34:56 EST</pubDate>
	 <guid isPermaLink="false">news281363669</guid>
	 
</item>
<item>
     <title>For drug makers, new 3-D control opens wealth of options</title>
   	 <description>A team of scientists anchored at Yale University has demonstrated a new, highly versatile approach for quickly assembling drug-like compounds, establishing a broad new route to drug discovery and medical treatment. They report their results in the journal Science on Feb 8.</description>
     <link>http://medicalxpress.com/news/2013-02-drug-makers-d-wealth-options.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 07 Feb 2013 14:00:09 EST</pubDate>
	 <guid isPermaLink="false">news279465907</guid>
	 
</item>
<item>
     <title>New target for treating wide spectrum of cancers</title>
   	 <description>(Medical Xpress)—UC Irvine biologists, chemists and computer scientists have identified an elusive pocket on the surface of the p53 protein that can be targeted by cancer-fighting drugs. The finding heralds a new treatment approach, as mutant forms of this protein are implicated in nearly 40 percent of diagnosed cases of cancer, which kills more than half a million Americans each year.</description>
     <link>http://medicalxpress.com/news/2013-01-wide-spectrum-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 31 Jan 2013 08:40:04 EST</pubDate>
	 <guid isPermaLink="false">news278842249</guid>
	 
</item>
<item>
     <title>Drug companies forge partnerships with top schools</title>
   	 <description>(AP)—Pharmaceutical companies that can no longer rely on lucrative patents to drive profits are increasingly teaming up with academia in search of the next big drug discovery.</description>
     <link>http://medicalxpress.com/news/2013-01-drug-companies-forge-partnerships-schools.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 10 Jan 2013 15:21:45 EST</pubDate>
	 <guid isPermaLink="false">news277053699</guid>
	 
</item>
<item>
     <title>ALS TDI and Gladstone Institutes collaborate to discover potential ALS treatments</title>
   	 <description>The ALS Therapy Development Institute (ALS TDI) and the Gladstone Institutes today announced the formation of a research collaboration to speed the discovery of potential treatments for ALS through the preclinical drug development process.</description>
     <link>http://medicalxpress.com/news/2012-12-als-tdi-gladstone-collaborate-potential.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 04 Dec 2012 10:33:11 EST</pubDate>
	 <guid isPermaLink="false">news273839583</guid>
	 
</item>
<item>
     <title>US meningitis death toll rises to 30, officials say</title>
   	 <description>The death toll from a meningitis outbreak linked to tainted drugs rose to 30 as the number of cases climbed to a whopping 419, US health officials said Monday.</description>
     <link>http://medicalxpress.com/news/2012-11-meningitis-death-toll.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 05 Nov 2012 18:20:40 EST</pubDate>
	 <guid isPermaLink="false">news271362028</guid>
	 
</item>
<item>
     <title>US firm loses license as tainted drug toll rises to 24</title>
   	 <description>US officials revoked the license Wednesday of a Massachusetts pharmacy cited for significant sanitary violations as the toll from a meningitis outbreak tied to its tainted drugs rose to 24.</description>
     <link>http://medicalxpress.com/news/2012-10-firm-tainted-drug-toll.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 25 Oct 2012 04:07:27 EST</pubDate>
	 <guid isPermaLink="false">news270356840</guid>
	 
</item>
<item>
     <title>US meningitis death toll up to 23: CDC</title>
   	 <description>The death toll in the United States from an unprecedented outbreak of fungal meningitis linked to a contaminated drug has climbed to 23 people, health officials said Saturday.</description>
     <link>http://medicalxpress.com/news/2012-10-meningitis-death-toll-cdc.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sat, 20 Oct 2012 17:23:52 EST</pubDate>
	 <guid isPermaLink="false">news269972622</guid>
	 
</item>
<item>
     <title>US meningitis outbreak death toll rises to 15</title>
   	 <description> The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.</description>
     <link>http://medicalxpress.com/news/2012-10-meningitis-outbreak-death-toll.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 14 Oct 2012 05:55:42 EST</pubDate>
	 <guid isPermaLink="false">news269412935</guid>
	 
</item>
<item>
     <title>US tainted drug outbreak rises to 185 cases</title>
   	 <description> The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.</description>
     <link>http://medicalxpress.com/news/2012-10-tainted-drug-outbreak-cases.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 12 Oct 2012 17:15:03 EST</pubDate>
	 <guid isPermaLink="false">news269280898</guid>
	 
</item>
<item>
     <title>Calls for more US oversight after tainted drug outbreak</title>
   	 <description> A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.</description>
     <link>http://medicalxpress.com/news/2012-10-oversight-tainted-drug-outbreak.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 11 Oct 2012 17:08:47 EST</pubDate>
	 <guid isPermaLink="false">news269194120</guid>
	 
</item>
<item>
     <title>Tainted drug death toll rises to 14 in US</title>
   	 <description> The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.</description>
     <link>http://medicalxpress.com/news/2012-10-tainted-drug-death-toll.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 11 Oct 2012 16:43:26 EST</pubDate>
	 <guid isPermaLink="false">news269192596</guid>
	 
</item>
<item>
     <title>Moving 3D computer model of key human protein is powerful new tool in fight against cancer</title>
   	 <description>A picture is worth 1,000 words when it comes to understanding how things work, but 3D moving pictures are even better. That's especially true for scientists trying to stop cancer by better understanding the proteins that make some chemotherapies unsuccessful.</description>
     <link>http://medicalxpress.com/news/2012-06-3d-key-human-protein-powerful.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 19 Jun 2012 13:10:06 EST</pubDate>
	 <guid isPermaLink="false">news259330185</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/moving3dcomp.jpg" width="90" height="90" />
</item>
<item>
     <title>New drug extends survival in patients with drug-resistant prostate cancer</title>
   	 <description>A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression of prostate cancer. Based on the strength of the data from the phase III trial, it is anticipated that the biopharmaceutical company Medivation, which licensed MDV3100, will file a new drug application with the Food and Drug Administration later this year.</description>
     <link>http://medicalxpress.com/news/2012-02-drug-survival-patients-drug-resistant-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Feb 2012 03:06:15 EST</pubDate>
	 <guid isPermaLink="false">news247287958</guid>
	 
</item>
<item>
     <title>Structural Genomics Project creates blueprint for infectious disease and biodefense research</title>
   	 <description>The September issue of the online scientific journal Acta Crystallographica: Structural Biology and Crystallization Communications (Acta Cryst F) will consist entirely of work done at the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory (PNNL). This free online edition features 30 peer-reviewed manuscripts, describing 40 unique infectious disease protein structures, as well as high-throughput gene-to-structure methodologies developed by SSGCID, and marks only the second time that Acta Cryst F has dedicated an entire issue to a single Structural Genomics center. The elucidation of such a large number of protein structures, all of which are freely available to scientific researchers to study and compare, provides a highly detailed &quot;blueprint&quot; for fighting infectious disease and bioterrorism.</description>
     <link>http://medicalxpress.com/news/2011-09-genomics-blueprint-infectious-disease-biodefense.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 01 Sep 2011 13:42:33 EST</pubDate>
	 <guid isPermaLink="false">news234103328</guid>
	 
</item>


</channel>
</rss>
